gms | German Medical Science

104th DOG Annual Meeting

21. - 24.09.2006, Berlin

Intraoperative administration of triamcinolone decreases the postoperative degree of inflammation after pars plana vitrectomy (PPV)

Meeting Abstract

  • A. Mańkowska - Department of Ophthalmology
  • R. Rejdak - Department of Ophthalmology
  • A. Oleszczuk - Department of Ophthalmology
  • M. Kiczyńska - Department of Ophthalmology
  • A. Łękawa - Department of Ophthalmology
  • T. Chorągiewicz - Department of Ophthalmology
  • Z. Zagórski - Department of Ophthalmology

Deutsche Ophthalmologische Gesellschaft e.V.. 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft (DOG). Berlin, 21.-24.09.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06dogP166

The electronic version of this article is the complete one and can be found online at:

Published: September 18, 2006

© 2006 Mańkowska et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.




To study the efficacy of triamcinolone acetonide (TA) injection during pars plana vitrectomy (PPV) to facilitate postoperative recovery in patients subjected to PPV.


Pars plana vitrectomy (PPV) was performed in 22 patients (13 male, 9 female) (14 with retinal detachment; 2 with cystoid macular edema, 2 with diabetic retinopathy, 3 with vitreous haemorrhage and 1 with lens luxation). After surgical separation of the posterior vitreous and removal of any visible epiretinal membrane, TA was injected over the posterior pole. For the control we used 11 patients (9 with retinal detachment, 1 with len’s luxation and 1 with diabetic retinopathy) (6 male, 5 female) treated with PPV but without TA administration. To evaluate the degree of postoperative inflammation and to monitor the dynamics of the blood-aqueous barrier disruption the laser flare cell meter (Kowa FM-500) was used.


Tyndalometric mean values in control eyes recorded 1 day after PPV were 32.6±8.1 ph/msec while values in TA-treated group were significantly lower (15.9±2.5, p<0.02). 10 days after surgery in TA group results were still significantly lower as compared to the control ( 9.5±1.0 vs 37.7±12.9, p<0.005). Importantly, as observed 30 days after PPV tydalometric recordings in TA-treated group remained lower as those observed in the control (9.6±1.3 vs 31.0±11, p<0.01).


The eyes which received TA-assisted PPV showed significantly less breakdown of the blood-ocular barrier than those with routine PPV. Intraoperative administration TA facilitates postoperative recovery after surgery lowering the degree of inflammation.